CLINICAL_TRIALS
trial_result
· 2016-10-28
Clinical Trial Update: The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients [Phase 3]
Summary
A Phase 3 clinical trial evaluating thalidomide for suppressing systemic inflammatory response syndrome in hemodialysis patients was terminated, with results po…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: George A. Kaysen, M.D. | Conditions: Hypoalbuminemia | Phase 3 | Status: TERMINATED | Results posted: 2016-10-28